Researchers are saying that, from an infection control perspective, C. auris acts more like a multidrug-resistant, healthcare-associated bacteria than like a typical yeast, according to an article on the MedPage website.
"It is a new bug using old tricks mastered by some well-known, multidrug resistant organisms," they said.
Identifying, treating, and preventing Candida auris is a challenge facing more and more healthcare settings.
Findings presented at the 2019 ASM Microbe meeting in San Francisco by researchers from the Centers for Disease Control and Prevention found that patients with C. auris appear to "shed" the pathogen from their skin into their environment, which could potentially play a factor in transmission.
Making AI Work for Predictive Maintenance
Thomas Jefferson University Unveils Plans for Sidney Kimmel Medical College in Allentown, PA
Aspirus Chippewa Falls Hospital and Clinic to Open in September
Respecting EVS Workers: 19 Minutes Is Not Enough
Where are the Greenhouse Gas Emissions Hotspots in Healthcare?